Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 2
2007 1
2009 2
2011 5
2012 1
2015 4
2016 5
2017 3
2018 2
2019 3
2020 2
2021 2
2022 7
2023 3
2024 6
2025 4
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Diseases and Injuries Collaborators. GBD 2021 Diseases and Injuries Collaborators. Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17. Lancet. 2024. PMID: 38642570 Free PMC article.
GBD estimates are updated routinely with additional data and refined analytical methods. GBD 2021 presents, for the first time, estimates of health loss due to the COVID-19 pandemic. ...YLLs were calculated by multiplying cause-age-sex-location-year-specific …
GBD estimates are updated routinely with additional data and refined analytical methods. GBD 2021 presents, for the first time …
Evidence to inform the future for maternal and newborn health.
Lawn JE, Blencowe H, Kinney MV, Bianchi F, Graham WJ. Lawn JE, et al. Best Pract Res Clin Obstet Gynaecol. 2016 Oct;36:169-183. doi: 10.1016/j.bpobgyn.2016.07.004. Epub 2016 Jul 28. Best Pract Res Clin Obstet Gynaecol. 2016. PMID: 27707540
Despite the impressive progress gains for maternal and child health during the Millennium Development Goals era, over 5.6 million women and babies died in 2015 due to complications during pregnancy, birth and in the first month of life. ...Priority actions in …
Despite the impressive progress gains for maternal and child health during the Millennium Development Goals era, over 5.6 mill …
The impact of Thailand's public health response to the HIV epidemic 1984-2015: understanding the ingredients of success.
Siraprapasiri T, Ongwangdee S, Benjarattanaporn P, Peerapatanapokin W, Sharma M. Siraprapasiri T, et al. J Virus Erad. 2016 Nov 28;2(Suppl 4):7-14. doi: 10.1016/S2055-6640(20)31093-1. J Virus Erad. 2016. PMID: 28275444 Free PMC article.
INTRODUCTION: Thailand has been heralded as a global leader in HIV prevention and treatment, and its experience with the HIV/AIDS epidemic holds valuable lessons for public health. ...In the context of Thailand's ageing population, it is faced with the twin challeng …
INTRODUCTION: Thailand has been heralded as a global leader in HIV prevention and treatment, and its experience with the HIV/AIDS epi …
Cost-effectiveness and health-related outcomes of screening for hepatitis C in Korean population.
Kim KA, Chung W, Choi HY, Ki M, Jang ES, Jeong SH. Kim KA, et al. Liver Int. 2019 Jan;39(1):60-69. doi: 10.1111/liv.13930. Epub 2018 Aug 10. Liver Int. 2019. PMID: 29998565
This study estimated the cost-effectiveness and health-related outcomes of HCV screening and DAA treatment of a targeted population in Korea, where anti-HCV prevalence was 0.6% in 2015. ...RESULTS: The HCV screening and DAA treatment strategy increased quality …
This study estimated the cost-effectiveness and health-related outcomes of HCV screening and DAA treatment of a targeted popul …
Impact and Cost-Effectiveness of Biomedical Interventions on Adult Hepatitis B Elimination in China: A Mathematical Modelling Study.
Wang X, Du Z, Wang Y, Wang J, Huang S, Wang Y, Gu J, Deng W, Gilmour S, Li J, Hao Y. Wang X, et al. J Epidemiol Glob Health. 2023 Sep;13(3):517-527. doi: 10.1007/s44197-023-00132-1. Epub 2023 Jun 22. J Epidemiol Glob Health. 2023. PMID: 37349664 Free PMC article.
METHODS: A deterministic compartmental model was developed to project the HBV epidemic from 2022 to 2050 and estimate the time to meet elimination targets under four intervention scenarios. Cost-effectiveness was calculated using incremental cost per …
METHODS: A deterministic compartmental model was developed to project the HBV epidemic from 2022 to 2050 and estimate the time …
Survival modelling and cost-effectiveness analysis of treatments for newly diagnosed metastatic hormone-sensitive prostate cancer.
Barbier MC, Tomonaga Y, Menges D, Yebyo HG, Haile SR, Puhan MA, Schwenkglenks M. Barbier MC, et al. PLoS One. 2022 Nov 3;17(11):e0277282. doi: 10.1371/journal.pone.0277282. eCollection 2022. PLoS One. 2022. PMID: 36327294 Free PMC article.
However, the optimal treatment strategy in terms of costs and effects is unclear, not least due to high ARAT costs. METHODS: To assess treatment cost-effectiveness, we developed a Markov cohort model with health states of progression-free disease, progressive diseas …
However, the optimal treatment strategy in terms of costs and effects is unclear, not least due to high ARAT costs. METHODS: To asses …
Cost-Effectiveness of Alirocumab: A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial.
Kazi DS, Penko J, Coxson PG, Guzman D, Wei PC, Bibbins-Domingo K. Kazi DS, et al. Ann Intern Med. 2019 Feb 19;170(4):221-229. doi: 10.7326/M18-1776. Epub 2019 Jan 1. Ann Intern Med. 2019. PMID: 30597485
TIME HORIZON: Lifetime. PERSPECTIVE: U.S. health system. INTERVENTION: Alirocumab or ezetimibe added to statin therapy. OUTCOME MEASURES: Incremental cost-effectiveness ratio in 2018 U.S. dollars per quality-adjusted life-year (QALY) g …
TIME HORIZON: Lifetime. PERSPECTIVE: U.S. health system. INTERVENTION: Alirocumab or ezetimibe added to statin t …
Evaluating the health and economic outcomes of a PCV15 vaccination program for adults aged 65 years-and-above in Switzerland.
Owusu-Edusei K, Favre-Bulle A, Tsoumani E, Mutschler T, Cossrow N. Owusu-Edusei K, et al. Vaccine. 2024 May 10;42(13):3239-3246. doi: 10.1016/j.vaccine.2024.04.016. Epub 2024 Apr 11. Vaccine. 2024. PMID: 38609806 Free article.
INTERVENTIONS: The three vaccination strategies examined were:Target population: All adults aged 65 years-and-above. ...OUTCOME MEASURES: Pneumococcal diseases (PD) i.e., invasive pneumococcal diseases (IPD) and non-bacteremic pneumococcal pneumonia (NBPP); total …
INTERVENTIONS: The three vaccination strategies examined were:Target population: All adults aged 65 years-and-above. ...OUTCOM …
Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.
de Boer PT, Nagy L, Dolk FCK, Wilschut JC, Pitman R, Postma MJ. de Boer PT, et al. Value Health. 2021 Jan;24(1):19-31. doi: 10.1016/j.jval.2020.10.011. Epub 2020 Dec 11. Value Health. 2021. PMID: 33431149 Free article.
The clinical and economic impact of different pediatric vaccination strategies were compared over 20 years, varying the targeted age range, the vaccine type for children or elderly and high-risk groups. Outcome measures include averted symptomatic infections and deaths …
The clinical and economic impact of different pediatric vaccination strategies were compared over 20 years, varying the targeted age …
Age-targeted vaccination for reducing Clostridioides difficile infection in England: a coupled mathematical-economic modelling analysis.
Yakob L, Allel K, Elragig A, Planche T, Mugwagwa T, Moïsi JC, Yu H. Yakob L, et al. BMC Med. 2025 Jul 15;23(1):426. doi: 10.1186/s12916-025-04265-x. BMC Med. 2025. PMID: 40660272 Free PMC article.
Model outputs of interest included medically attended cases, intensive care admissions and deaths associated with CDI, as well as costs and quality-adjusted life years (QALYs). Hospital costs and costs of years of life lost due to premature mortality a …
Model outputs of interest included medically attended cases, intensive care admissions and deaths associated with CDI, as well as cos …
50 results